Towards a consensus on a hearing preservation classification systemHenryk Skarżyńśki, Griet Mertens, K. Green et al.|Acta Oto-Laryngologica|2013Cited by 222
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancerWojciech Krajewski, Ekaterina Laukhtina, Júlia Aumatell et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 29
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021Nicola L. Barclay, Marek Oja, Edward Burn et al.|Scientific Reports|2024Cited by 25
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk DynamicsJosé Daniel Subiela, F.J. Burgos Revilla, Wojciech Krajewski et al.|European Urology Oncology|2024Cited by 20
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapyRadosław Piszczek, Tomasz Szydełko, Wojciech Krajewski et al.|Minerva Urology and Nephrology|2023Cited by 9